Etoricoxib Prescribing Patterns and Adverse Events of Interest in Primary Care in the United Kingdom (MK-0663-162 AM1)
Status:
Completed
Trial end date:
2015-03-01
Target enrollment:
Participant gender:
Summary
This postmarketing study was conducted to describe prescribing patterns for etoricoxib
(ARCOXIA®) in General Practice and describe the incidence of selected adverse events recorded
in the United Kingdom (UK) Medicines and Health Care Products Regulatory Agency (MHRA)
General Practice Research Database (GPRD).